Novocure (NVCR) Misses Q4 EPS by 25c

Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.61), $0.25 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $161.26 million versus the consensus estimate of $153.04 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Amer Sports Inc. (AS) PT Lowered to $42 at Truist, but 'Momentum continues to surge in a tough macro'
• Truist's 2Q26 Off-Cycle Earnings Preview for Cybersecurity Software: 'We favor RBRK and SAIL'
• Benchmark Reiterates Buy Rating on Synopsys (SNPS) Amid 'Relatively Bearish' Sentiment Into Earnings